Conduit Pharmaceuticals Announces Board and Compensation Changes
Ticker: CDTTW · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Conduit Pharma's board and exec pay got a shake-up.
AI Summary
Conduit Pharmaceuticals Inc. announced on April 12, 2025, a change in its board of directors and executive compensation arrangements. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is based in Naples, Florida, and operates in the pharmaceutical preparations industry.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial priorities that may impact future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company direction and stability.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- April 12, 2025 (date) — Date of earliest event reported
- November 30, 2021 (date) — Date of former company name change
- Naples, Florida (location) — Company business address
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not detail the specific individuals or the nature of the changes in this excerpt.
What are the details of the new compensatory arrangements?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not provided in this initial summary.
When did the company change its name from Murphy Canyon Acquisition Corp.?
The company changed its name from Murphy Canyon Acquisition Corp. on November 30, 2021.
What is Conduit Pharmaceuticals Inc.'s primary business sector?
Conduit Pharmaceuticals Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the filing date for this 8-K report?
This 8-K report was filed as of April 16, 2025, with the earliest event reported on April 12, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).